J&J(US:JNJ) Businesswire·2025-12-23 04:15Core Viewpoint - A Baltimore jury awarded Cherie A. Craft over $1.5 billion after determining that Johnson & Johnson and its subsidiaries exposed her to asbestos through talc-based personal care products, leading to her diagnosis of peritoneal malignant mesothelioma, an incurable cancer. This verdict is noted as the largest ever against Johnson & Johnson for a single plaintiff [1]. Group 1 - The jury's verdict in favor of Cherie A. Craft is significant, marking a potential turning point in legal challenges against Johnson & Johnson regarding their talc products [1]. - The amount awarded, over $1.5 billion, highlights the severity of the case and the implications for Johnson & Johnson's financial liabilities [1]. - The diagnosis of peritoneal malignant mesothelioma, linked to asbestos exposure, raises concerns about the safety of talc-based products in the personal care industry [1].